Screener
Tenet Healthcare THC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Tenet Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Tenet Healthcare’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:27 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0000070318-26-000037
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other items, net | (4) | (22) |
| Net cash used in financing activities | (2,419) | (1,644) |
| Net decrease in cash and cash equivalents | (713) | (394) |
| Cash and cash equivalents at beginning of period | 2,883 | 3,019 |
| Cash and cash equivalents at end of period | $2,170 | $2,625 |
| Supplemental disclosures: | ||
| Interest paid, net of capitalized interest | $(365) | $(399) |
| Income tax payments, net | $(330) | $(242) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Tenet Healthcare's cash & equivalents?
- Tenet Healthcare (THC) reported cash & equivalents of $2.17B in Q2 2026.
- How has Tenet Healthcare's cash & equivalents changed year-over-year?
- Tenet Healthcare's cash & equivalents decreased by 17.3% year-over-year, from $2.63B to $2.17B.
- What is the long-term trend for Tenet Healthcare's cash & equivalents?
- Over 4 years (2021 to 2025), Tenet Healthcare's cash & equivalents has grown at a 5.1% compound annual growth rate (CAGR), from $2.36B to $2.88B.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Tenet Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude